Fiona Hegi-Johnson

AUTOMATED RADIOSYNTHESIS OF [(89)ZR]ZR-DFOSQ-DURVALUMAB ON THE IPHASE MULTISYN MODULE

C Wichmann, S Poniger, N Guo, P Roselt, S Rudd, P Donnelly, F Hegi-Johnson, M MacManus, A Scott

Conference Proceedings  |  2021  |  INTERNAL MEDICINE JOURNAL

Impact of Primary Subtype on Pattern of Metastases and Survival in Young Women with Metastatic Breast Cancer

R Alomran, J Xie, F Hegi-Johnson, J Philip, PKL Tran

Conference Proceedings  |  2020  |  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Pattern of Palliative Radiotherapy in Young Women with Metastatic Breast Cancer

R Alomran, J Xie, F Hegi-Johnson, J Philip, PKL Tran

Conference Proceedings  |  2020  |  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Collaborative implementation of stereotactic ablative body radiotherapy: A model for the safe implementation of complex radiotherapy techniques in Australia

Eric Hau, Fiona Hegi-Johnson, Charlotte Atkinson, Jeffrey Barber, Lois H Browne, Yaw Chin, Patrick Dwyer, Peter H Graham, Jolyne O'Hare, Dan Lu, Melissa Rains, Carolina Ragusa, Laurel Schmidth, Katherine Small, Kylie Unicomb, Katrina West, Sean White, Andrew Last, Jane Ludbrook, Maria Azzi, et al.

Journal article  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

INTRODUCTION: Stereotactic ablative radiotherapy (SABR) for lung cancer is a modality of treatment that has improved outcomes for ..

Helping patients with lung cancer choose between surgery or stereotactic body radiotherapy: the importance of the patient experience

Michael MacManus, Richard De Abreu Lourenco, Fiona Hegi-Johnson

Journal article  |  2019  |  JOURNAL OF THORACIC DISEASE

What Influences Patient Decision-Making About Lung-Cancer Treatment? A Discrete Choice Experiment

F Hegi-Johnson, M Haas, D Ball, G Wright, R De Abreu Lourenco

Conference Proceedings  |  2019  |  JOURNAL OF THORACIC ONCOLOGY

Molecular Biology of Radiation Toxicity

F Hegi-Johnson

Conference Proceedings  |  2019  |  JOURNAL OF THORACIC ONCOLOGY

Imaging of regional ventilation: Is CT ventilation imaging the answer? A systematic review of the validation data

Fiona Hegi-Johnson, Dirk de Ruysscher, Paul Keall, Lizza Hendriks, Yevgeniy Vinogradskiy, Tokihiro Yamamoto, Bilal Tahir, John Kipritidis

Journal article  |  2019  |  RADIOTHERAPY AND ONCOLOGY

Computed Tomography Ventilation Imaging (CTVI) is an experimental imaging modality that derives regional lung function information..

Patterns of care for stage III non-small cell lung cancer in Australia

Phillip Parente, Bryan A Chan, Brett GM Hughes, Kevin Jasas, Rohit Joshi, Steven Kao, Fiona Hegi-Johnson, Rina Hui, Sara McLaughlin-Barrett, Ina Nordman, Emily Stone

Journal article  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Stage III non-small cell lung cancer (NSCLC) makes up a third of all NSCLC cases and is potentially curable. Despite this 5-year s..

The VAMPIRE challenge: A multi-institutional validation study of CT ventilation imaging

John Kipritidis, Bilal A Tahir, Guillaume Cazoulat, Michael S Hofman, Shankar Siva, Jason Callahan, Nicholas Hardcastle, Tokihiro Yamamoto, Gary E Christensen, Joseph M Reinhardt, Noriyuki Kadoya, Taylor J Patton, Sarah E Gerard, Isabella Duarte, Ben Archibald-Heeren, Mikel Byrne, Rick Sims, Scott Ramsay, Jeremy T Booth, Enid Eslick, et al.

Journal article  |  2019  |  MEDICAL PHYSICS

PURPOSE: CT ventilation imaging (CTVI) is being used to achieve functional avoidance lung cancer radiation therapy in three clinic..